Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elective Blastocyst Vitrification in High-Responders (ICE)
NCT02148393Completed
- Sponsor
- UZ Brussel
- Start
- May 2014
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by UZ Brussel. Primary endpoint: Clinical pregnancy rates at 7 weeks. Started May 2014; status: completed.
Beyond the preview
Go deeper on NCT02148393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02148393.